DE60025370D1 - 9a-azalide mit antibakterieller wirkung - Google Patents

9a-azalide mit antibakterieller wirkung

Info

Publication number
DE60025370D1
DE60025370D1 DE60025370T DE60025370T DE60025370D1 DE 60025370 D1 DE60025370 D1 DE 60025370D1 DE 60025370 T DE60025370 T DE 60025370T DE 60025370 T DE60025370 T DE 60025370T DE 60025370 D1 DE60025370 D1 DE 60025370D1
Authority
DE
Germany
Prior art keywords
azalides
antibacterial effect
antibacterial
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60025370T
Other languages
English (en)
Other versions
DE60025370T2 (de
Inventor
Yat Sun Or
Robert F Keyes
Zhenkun Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE60025370D1 publication Critical patent/DE60025370D1/de
Publication of DE60025370T2 publication Critical patent/DE60025370T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DE60025370T 1999-08-24 2000-07-26 9a-azalide mit antibakterieller wirkung Expired - Fee Related DE60025370T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38216699A 1999-08-24 1999-08-24
US382166 1999-08-24
PCT/US2000/020363 WO2001014397A1 (en) 1999-08-24 2000-07-26 9a-azalides with antibacterial activity

Publications (2)

Publication Number Publication Date
DE60025370D1 true DE60025370D1 (de) 2006-03-30
DE60025370T2 DE60025370T2 (de) 2006-09-21

Family

ID=23507795

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025370T Expired - Fee Related DE60025370T2 (de) 1999-08-24 2000-07-26 9a-azalide mit antibakterieller wirkung

Country Status (15)

Country Link
EP (1) EP1206476B1 (de)
JP (1) JP2003507487A (de)
AR (1) AR025379A1 (de)
AT (1) ATE315042T1 (de)
AU (1) AU6748500A (de)
BR (1) BR0009101A (de)
CA (1) CA2380455C (de)
CY (1) CY1104996T1 (de)
DE (1) DE60025370T2 (de)
DK (1) DK1206476T3 (de)
ES (1) ES2256030T3 (de)
HK (1) HK1047940B (de)
MX (1) MXPA02001897A (de)
PT (1) PT1206476E (de)
WO (1) WO2001014397A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
EP2988597B1 (de) 2013-04-04 2022-06-08 President and Fellows of Harvard College Makrolide sowie verfahren zu deren herstellung und verwendung
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (de) 2015-03-25 2018-11-21 President and Fellows of Harvard College Makrolide mit modifizierten desosaminzuckern und verwendungen davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
WO1994026758A1 (en) * 1993-05-19 1994-11-24 Pfizer Inc. Intermediate for azithromycin
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AU7961498A (en) * 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
AU7986098A (en) * 1997-06-27 1999-01-19 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1101769A3 (de) * 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate

Also Published As

Publication number Publication date
EP1206476A1 (de) 2002-05-22
MXPA02001897A (es) 2002-10-31
JP2003507487A (ja) 2003-02-25
CA2380455C (en) 2009-06-02
ATE315042T1 (de) 2006-02-15
HK1047940A1 (en) 2003-03-14
DK1206476T3 (da) 2006-05-15
PT1206476E (pt) 2006-05-31
CA2380455A1 (en) 2001-03-01
ES2256030T3 (es) 2006-07-16
CY1104996T1 (el) 2010-03-03
EP1206476B1 (de) 2006-01-04
DE60025370T2 (de) 2006-09-21
WO2001014397A1 (en) 2001-03-01
HK1047940B (zh) 2006-11-03
AU6748500A (en) 2001-03-19
BR0009101A (pt) 2002-02-05
AR025379A1 (es) 2002-11-20

Similar Documents

Publication Publication Date Title
DE60014893D1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
DE60006227D1 (de) Antimikrobielle gegenstände
ATE329566T1 (de) Pflaster mit magnetischer wirkung
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
DE60012526D1 (de) Hydrophile polypropylenfasern mit antimikrobieller wirkung
DE69934805D1 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
DE60036160D1 (de) Elektroentionisierungsvorrichtung
DE60113450D1 (de) Antimikrobielle chinolone
NO20021183L (no) Antimikrobielle tilsetningsstoffer
NO20010916D0 (no) Nye antibakterielle isoksazolinoner
NO20015722D0 (no) Antibakterielle forbindelser
DE69908338D1 (de) 15-gliedrige ketolid-lactame mit antibakterieller wirkung
NO20015744D0 (no) Bredspektrede antimikrobielle blandinger
DE60125678D1 (de) Vermittlungstelle mit Flusssteurungverwaltung
DE60333379D1 (de) Tricyclische tetrahydrochinoline mit antibakterieller wirkung
DE60008126D1 (de) Antimikrobieller polymer
DE69927008D1 (de) Verbindungen mit kalzilytischer wirkung
ATE408596T1 (de) Pleuromutilinderivate mit antibakterieller wirkung
NO20020621D0 (no) Antibakterielle midler
ATE264843T1 (de) Antibakterielle mutiline
ATE248579T1 (de) Synergistische antibakterielle kombination
DE60025370D1 (de) 9a-azalide mit antibakterieller wirkung
IS6223A (is) Fjölbrigða salt
ATE235491T1 (de) Phenylpyrazole mit herbizider wirkung
ID25567A (id) Ulir-jepit dengan bahu-puntir

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee